Profound Medical Files 6-K, Attaches Feb 15 Press Release
Ticker: PROF · Form: 6-K · Filed: Feb 15, 2024 · CIK: 1628808
| Field | Detail |
|---|---|
| Company | Profound Medical Corp. (PROF) |
| Form Type | 6-K |
| Filed Date | Feb 15, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, press-release
TL;DR
**Profound Medical just filed a 6-K, indicating a new press release is out today.**
AI Summary
Profound Medical Corp. filed a Form 6-K with the SEC on February 15, 2024, under Commission File Number 001-39032. This filing serves to furnish a press release dated February 15, 2024, which is attached as Exhibit 99.1. The document itself does not disclose the content of the press release, only its official submission to the U.S. Securities and Exchange Commission.
Why It Matters
This administrative filing signals that Profound Medical Corp. has released new, potentially material information to the public via a press release. Investors should review the referenced Exhibit 99.1 to understand any new developments that could impact the company.
Risk Assessment
Risk Level: low — The filing itself is purely administrative, merely announcing the submission of a press release without revealing its content, thus posing no direct risk from this document alone.
Key Players & Entities
- Profound Medical Corp. (company) — registrant
- February 15, 2024 (date) — filing date and press release date
- 001-39032 (other) — Commission File Number
FAQ
What type of filing did Profound Medical Corp. submit?
Profound Medical Corp. submitted a Form 6-K.
On what date was this 6-K filed?
The 6-K was filed on February 15, 2024.
What is the primary purpose of this 6-K filing?
The primary purpose is to furnish a press release dated February 15, 2024, as Exhibit 99.1.
What is Profound Medical Corp.'s Commission File Number?
Profound Medical Corp.'s Commission File Number is 001-39032.
Where is Profound Medical Corp.'s principal executive office located?
Its principal executive office is at 2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5.
Filing Stats: 165 words · 1 min read · ~1 pages · Grade level 12.9 · Accepted 2024-02-15 16:45:11
Filing Documents
- f6k_021524.htm (6-K) — 5KB
- exh_991.htm (EX-99.1) — 5KB
- 0001171843-24-000837.txt ( ) — 10KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. PROFOUND MEDICAL CORP. (Registrant) Date: February 15, 2024 /s/ Rashed Dewan Rashed Dewan Chief Financial Officer